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Abstract
CD8+ cytotoxic T lymphocytes (CTLs), natural killer (NK) cells, B cells and target cell limitation have all been suggested to
play a role in the control of SIV and HIV-1 infection. However, previous research typically studied each population in
isolation leaving the magnitude, relative importance and in vivo relevance of each effect unclear. Here we quantify the
relative importance of CTLs, NK cells, B cells and target cell limitation in controlling acute SIV infection in rhesus macaques.
Using three different methods, we find that the availability of target cells and CD8+ T cells are important predictors of viral
load dynamics. If CTL are assumed to mediate this anti-viral effect via a lytic mechanism then we estimate that CTL killing is
responsible for approximately 40% of productively infected cell death, the remaining cell death being attributable to
intrinsic, immune (CD8+ T cell, NK cell, B cell) -independent mechanisms. Furthermore, we find that NK cells have little
impact on the death rate of infected CD4+ cells and that their net impact is to increase viral load. We hypothesize that NK
cells play a detrimental role in SIV infection, possibly by increasing T cell activation.
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Introduction
During the early stage of infection with human or simian
immunodeficiency virus type 1 (HIV-1, SIV-1) the number of
circulating virus particles increases rapidly, typically doubling
every 6–10 hours [1–4]. This is accompanied by the fast
destruction of CD4+ T cells in the mucosa and to a lesser extent
in the periphery [5–7]. Subsequently, in virtually all infected
individuals, viral load starts to decline and falls to a relatively stable
level or set point that is typically several orders of magnitude lower
than the peak viral load [8–10]. What causes this reproducible and
robust, yet ultimately incomplete, control of viral replication is still
unclear. Understanding the factors that are naturally effective in
controlling virus infection may be key to engineering practical and
widely applicable treatment for control of HIV-1 infection. Some
of the main factors that have been postulated to play a role are
CD8+ cytotoxic T lymphocytes (CTLs), natural killer (NK) cells, B
cells and target cell limitation.
SIV/HIV-1-specific CD8+ cytotoxic T cells are widely consid-
ered to help control SIV andHIV-1. Observations supporting a role
for CD8+ T cells in the containment of immunodeficiency virus are
i) the temporal association between the appearance of HIV- or SIV-
specific CD8+ T cell responses and the post-peak decline in viral
load [11–13], ii) the significant association of particular MHC-class
I alleles with protection fromHIV-1 disease progression [14], iii) the
dramatic increase in SIV viral load after in vivo depletion of CD8+
T cells [15–17], and iv) the existence of multiple viral mechanisms to
evade the CTL response, including down-regulation of HLA class I
A and B molecules from the surface of infected cells [18] and
evolution of mutated forms of viral epitopes that escape CD8+ T cell
surveillance [19]. However, numerous studies have reported that
CD8+ T cells are poorly functional in HIV-1 infection [20], possibly
due to exhaustion [21,22], CD4+ depletion and/or an immature
phenotype [23,24]. For instance, the fraction of PD-1+CD8+T cells
is more than two-fold higher in HIV-specific compared to the total
population [21] and the proportion of CD27+ cells is above 50% in
HIV-specific T cells compared to well below 50% in CMV-specific
T cells [23]. Furthermore, quantification of the selection pressure
exerted by CTL responses in HIV-1-infected individuals in vivo
suggested that only a minority (20–40%) of productively-infected
CD4+ cell death in chronic/late primary infection is attributable to
CTL killing [25].
To control their cytotoxic activity, NK cells possess two types of
surface receptors: activating receptors, whose ligands include certain
stress molecules, and inhibitory receptors, which bind MHC class I
molecules. Integration of signals from these receptors determines
NK lytic function [26]. Evidence for a role of NK cells in the control
of HIV-1 infection is comparable to the evidence for CD8+ T cell
control. Several studies [27,28] report an expansion of the cytolytic
CD56-dim NK cell subset in acute HIV-infection. Depletion of
cytolytic CD16+ NK cells, although short-lived and incomplete,
showed a trend towards higher levels of SIV replication in NK cell-
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depleted monkeys compared to control monkeys [29]. Furthermore,
HIV escapes NK cell recognition by preventing the down-
regulation of HLA-C/E molecules [18] and restricts the up-
regulation of ligands for activating NK cells receptors like MICA,
ULBP1 and 2 [30] and NKp44L [31]. Lastly, an activating NK cell
receptor (KIR3DS1), in combination with its putative ligand (HLA-
B Bw40-80I) has been shown to be associated with slower HIV-1
disease progression [32] while in HIV-exposed uninfected individ-
uals a higher prevalence of KIR3DS1 homozygosity was found
[33]. This may be caused by preferential activation and expansion
of KIR3DS1- or KIR3DL1-expressing NK cells and subsequent
inhibition of HIV-1 replication [34–37]. However, O’Connell et al
[38] did not find that KIR3DS1 was overrepresented in a cohort of
Elite Suppressors (ES) and concluded that strong NK cell-mediated
inhibition of viral replication is not necessary for the control of HIV-
1 in all ES. Moreover, various studies found a decline in number
and lytic function of NK cells from early in infection
[39–41].
Evidence for the role of B cells includes the rapid and
continuous in vivo evolution of Env, the primary target for
neutralizing antibodies [42,43] and a negative correlation between
the level of neutralizing Abs and viral load during chronic [44],
but not acute infection [45]. Additionally, depletion of B cells in
rhesus macaques has demonstrated that humoral immune
responses may help to control viraemia during the immediate
post-acute phase of infection [46,47]. However, Gaufin et al [48]
found no significant effect of B cell depletion on viral load in SIV
infection in African Green Monkeys, concluding that humoral
immune responses play only a minor role in the control of viral
replication in the natural host. Furthermore, HIV-associated
premature exhaustion of B cells has been described and may
contribute to poor antibody responses against HIV [49].
An alternative to immune control is target cell limitation [50].
Using mathematical modelling, Phillips [50] demonstrated that the
post-peak decline of virus load could be due to the loss of CD4+ T
cells as targets for viral replication. Experimental work supporting
a role for target cell limitation includes studies describing post-
peak viral decline in the absence of a specific immune response
[51–53]. Further support is provided by studies that found a
reduction in set point viral load when the immune system was
artificially suppressed [54–57] or an increase in set point viral load
when target cell levels were increased, for instance by IL-2 [58,59]
or vaccination [60–65]. However, more recent theoretical work
has questioned the importance of target cell limitation [66,67] and
Zhang et al [68] found an increase in activated CD4+ T cells in the
lymphatic tissues of acutely SIV-infected rhesus macaques, even as
levels of virus in plasma fell.
In short, studies of each of these factors, namely CD8+ T cells,
NK cells, B cells and target cell limitation, have found evidence for
their anti-viral activity. But the magnitude, relative importance
and in vivo relevance of these effects is unclear. At least part of the
problem is that studies have tended to focus on each factor in
isolation. The aim of this work was to quantify the relative
importance of CD8+ T cells, NK cells, B cells cytolytic activity and
target cell limitation in controlling acute SIV viraemia.
Results
The factors determining early SIV viral load in 17 experimen-
tally infected rhesus macaques were investigated using three
different approaches. First, simple empirical models were used to
assess the temporal (‘‘Granger–causal’’) relationship between viral
load, target cells and immune populations within each animal.
Secondly, different mechanisms of viral control were studied using
mechanistic dynamical models. Finally, we assessed the ability of
each cell population to predict viral load variation across the
cohort. The first and the third approach make no assumption
about the mechanism of target cell and immune cell action. In the
second, mechanistic, approach we investigated different, plausible
modes of action.
Granger causality
Combination of CD4+ and CD8+ T cells gives the best
prediction of viral load. Granger causality is a weak definition
of causality originally developed in economics [70] and now used
in all branches of science. If an explanatory variable is able to help
predict the future values of a dependent variable then the
explanatory variable is said to ‘‘Granger-cause’’ the dependent
variable.
We investigated the Granger-causal determinants of viral load.
For each of the immune cell populations of interest (CD8+ T cells,
NK cells, B cells) we asked whether that population, alone or in
combination with CD4+ target cells, or target cells alone, was a
significantly better predictor of future viral load than past viral
load alone. Importantly, Granger-causality makes no assumption
about the mechanism of action i.e. it is essentially a hypothesis-free
method. We used a population approach through a Bayesian
framework which provides increased power to distinguish between
different models. Results are shown in Table 1. We found that the
best fit, indeed the only model to show a substantial improvement
over viral load alone, was a model including CD8+ T cells and
CD4+ T cells (Figure 1). Weak support was found for a model with
CD4+ cells alone. There was no support for models containing NK
cells or B cells either alone, or in combination with CD4+ cells.
Reversing the process to test whether viral load causes CD8+ T
cell dynamics we found that although there was a trend, viral load
was not a significant predictor of future numbers of CD8+ T cells.
There was some support for a role of viral load in the prediction of
CD4+ T cells (Table 1B).
We conclude that CD8+ T cells and CD4+ target cells are
Granger-causal determinants of SIV viral load. Importantly, this
result did not follow trivially from viral load driving CD8+ T cell
expansion as viral load was not a strong predictor of CD8+ T cells.
B cells and NK cells are not causal predictors of viral load, even
with this weak definition of causality.
Mechanistic models
CD8+ immune control explains viral dynamics
best. Mechanistic models are widely used in biology to
investigate population dynamics. We used the approach of
Regoes et al ([66], Methods) to test whether immune control by
Author Summary
The role of the immune response in controlling HIV
infection, or its simian counterpart SIV, has not been fully
elucidated. Different studies have provided evidence of a
role for different components of the immune system.
Unfortunately, the different components are usually
studied in isolation, making it hard to determine their
relative importance. Here we study three main immune
cell populations, T, B and NK cells, in parallel and found
that cytotoxic T cells play the largest role in the control of
SIV infection, but were not responsible for the majority of
infected cell death. Interestingly, we found indications
that, although NK cells contribute to the killing of infected
cells, the net impact of the NK response is to increase viral
load.
Role of the Immune System in Primary SIV-Infection
PLoS Computational Biology | www.ploscompbiol.org 2 March 2011 | Volume 7 | Issue 3 | e1001103
CD8+ T cells, NK cells, B cells or target cell limitation accounts
best for the viral dynamics in acute SIV infection. Again, we
implemented the fitting in a Bayesian framework in which models
were fitted to all animals simultaneously. Although, this naturally
results in less good fits to data from each individual animal it gives
increased power to distinguish between models and should be
better to predict the dynamics in new animals.
We found that the CD8+ T cell control model best describes the
experimental viral load data. Figure 2 shows that the fit of the
CD8 control model, represented by the sum of squared residuals,
is consistently better than the fit of any of the other three models.
The target cell limitation model yields poor fits (Figure 3) and,
compared to the CD8 control model, gains no support (Table 2A).
The NK cell control model also performs poorly. The fit of the B
cell control model, although better than the target cell and NK
models, does not compete with the CD8+ T cell control model. In
the CD8+ T cell control model described above, CD8+ T cells are
assumed to mediate control via a lytic mechanism. If CD8+ T cells
are assumed to operate via a non-lytic mechanism then this
provides a further improvement in the fits (Table S1), and
confirms the importance of CD8+ T cells in predicting HIV
dynamics. The oscillations in the predicted viral load are due to
the large variation in the experimental data underlying the
empirical functions describing the dynamics of target and immune
cell populations. Smoothing of the input data reduces the
fluctuations.
No improvements in fit were found when we repeated the
simulations using the Ki67+ fraction of each cell population
(Table 2B). Similarly, repeating the simulations with Env- and
Gag-specific CD8+ T cells also did not yield an improvement in
the fits.
Combination of two or three immune cell populations does not
substantially improve the prediction of viral dynamics for most
combinations (Table 2C). Only the combination of CD8+ T and
CD20+ B cells in one model gets some support, but it is only
marginally better than the simpler model with CD8 cell control
only. When applying the least squares regression approach to
models with two or more effector populations, searching for point
estimates instead of posterior distributions, we found that in most
cases all killing rates except for CD8 cells were estimated to be
zero (data not shown).
Quantification of the impact of different immune effector
populations. Next, in a model in which each of the immune
effector cells was allowed to exert an antiviral effect via infected
cell lysis, we quantified the contribution of the different immune
cell populations to productively infected cell death (Methods,
Table 3). We found that, in this model, the main causes of infected
CD4+ T cell death are the intrinsic (CD8, NK and B-independent)
death rate, accounting for almost half of infected cell death (47%),
and CD8+ T cell killing (42%). B cells and NK cells play only a
minor role in the death of productively infected cells (both
approximately 6%).
These results support the findings of Grangers causality,
identifying CD4+ and CD8+ T cells as the most important factors
in the containment of viral replication, giving no substantial
support to NK and B cell-mediated control of SIV-infected cells.
Possible alternative role for NK cells in SIV-
infection. Next we asked, in a simple correlation analysis,
how much of the variation in viral load across the cohort at time t
could be explained by variation in the various factors at the
previous time point (see Methods, partitioning of R2, and Table 4).
Surprisingly, given the minor role which we had found for them in
killing infected cells, NK cells predicted a high proportion of
variation in future viral load (15.3%).
Based on this large contribution of NK cells to explaining
experimental variance in viral load but not killing, in combination
with a consistent positive effect of NK cells on viral load found in
the Granger regression when including all three immune
populations (data not shown), we decided to test how releasing
the parameter constraints on the killing rates of CD8+ T cells, NK
cells and B cells would affect the prediction of viral load in the
mechanistic model. Because no quantitative information is
available regarding a possible positive contribution of immune
effectors to viral load, we used uninformative prior distributions in
these model fits.
We found strong support for liberating parameter constraints in
the mechanistic model, with a striking decrease in DIC of ,43
from CD8+ immune control model and a considerable improve-
ment in fit (Figure 3). Consistent with the results from Granger
regression and the constrained mechanistic model we found that
the effect of CD8+ T cells on viral load was consistently negative,
indicating that the net impact of CD8+ T cells in all macaques is to
reduce viral load. In contrast, the effect of NK cells on viral load
was found to be positive for all macaques, suggesting that in this
data set NK cells can contribute to an increase in viral load. For B
cells we found a positive effect on viral load in 6 animals and a
negative effect in 5 animals (Table S2). To quantify the impact of
intrinsic cell death and immune cell killing on viral load we
calculated the change in log VL per hour attributable to each
factor. We found a small decrease attributable to intrinsic cell
death (median - 0.009 log SIV RNA/ml plasma/h), a larger
decrease due to CD8+ T cells (median - 0.046), an increase due to
NK cells (median +0.022) and a small impact for B cells (median
+0.004). These estimates varied between animals but were highly
consistent within animals across different time points (Table S3).
Table 1. Granger causality model inference.
Dependent Predictors DDIC
A Vt Vt-t, Tt-t 22.6
Vt Vt-t, CD8t-t 220.5
Vt Vt-t, NKt-t 218.5
Vt Vt-t, Bt-t 25.4
Vt Vt-t, Tt-t, CD8t-t 5.8
Vt Vt-t, Tt-t, NKt-t 213.9
Vt Vt-t, Tt-t, Bt-t 222.0
B CD8t CD8t-t, Vt-t 1.6
NKt NKt-t, Vt-t 20.3
Bt Bt-t, Vt-t 3.4
Tt Tt-t, Vt-t 3.6
Comparison of A) Do any of the lymphocyte populations Granger-cause viral
load? The Deviance Information Criterion (DIC) of the simplest model (past viral
load predicts future viral load) was compared with the DIC of alternative models
in which past viral load and a range of different lymphocyte populations (alone
or in combination as specified in the table) were predictors of future viral load.
B) Does viral load Granger-cause the lymphocyte populations? The analysis was
reversed and the DIC of the listed models is compared with the DIC of models
including only one of the lymphocyte populations as predictor (i.e. without viral
load). DDIC is defined as DIC of the simplest model minus the DIC of the more
complex model. As a rule of thumb we consider strong support for the simplest
model when DDIC is ,2, more support for the more complex model when
DDIC,7 and strong support for the complex model when DDIC.10 [90]. Vt:
viral load at time t. Tt: CD4
+ T cells at time t. CD8t: CD8
+ T cells at time t. NKt: NK
cells at time t. Bt: B cells at time t. The only model to show a large improvement
over the simplest model with past viral load only was a model with past CD8+ T
cells and target cells (in bold above).
doi:10.1371/journal.pcbi.1001103.t001
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Discussion
Different factors have been postulated to play a role in
viral control in immunodeficiency virus infection, notably
target cell limitation, CD8+ T cells, NK cells and B cells.
As these factors are usually studied in isolation, their re-
lative importance and in vivo relevance has not yet been
quantified.
Figure 1. Experimental data and fits of empirical model (Granger-causality). Experimental viral load and viral load predicted by a regression
of past VL, past CD4+ T cells and past CD8+ T cells for each of the 11 datasets.
doi:10.1371/journal.pcbi.1001103.g001
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We used three different methods to assess the relative
importance of target cells, CD8+ T cells, NK cells and B cells in
determining SIV viral load in rhesus macaques. All three methods
found that target cell limitation alone cannot explain SIV viral
load dynamics and that including CD8+ T cells resulted in
substantially better predictions. Two of the three methods make no
assumptions about the mode of action of CD8+ T cells. In the third
method (mechanistic modeling) we showed that our conclusions
were the same whether we assumed a lytic or a non-lytic mode of
action of immune effector cells [71–73]. Including NK cells or B
cells did not result in a substantial improvement in predictive
ability.
The finding that CD8+ T cells were significant predictors of
viral load dynamics did not follow trivially from viral load driving
CD8+ T cell expansion, as Granger analysis showed that viral load
was not a strong predictor of CD8+ T cells. There are a number of
possible reasons why viral load may be poorly predictive of CD8+
T cell dynamics. One explanation is that antigen only needs to be
above a threshold to generate CD8+ T cells. Another is that the
maximum number of specific CTLs is limited and that this limit is
reached relatively early in infection so a possible effect of viral
dynamics on CD8+ T cell dynamics will only be captured when
simulating very early HIV infection.
Quantification of the contribution of different death terms
showed that CD8+ T cell killing and intrinsic cell death were the
main causes of productively infected cell death. We estimate that
approximately 40% of infected cell death can be attributed to
CD8+ T cell killing, consistent with our previous estimates of
CD8+ T cell killing based on the strength of selection for escape
variants (20–40% in HIV-infected humans [25], more in SIV-
infected macaques [74]). This relatively small role for CD8+ T cells
may explain the reported lack of an association between the rate of
viral clearance and disease stage of the individual [75].
Surprisingly, NK cell numbers explain a large part of the
variance in viral load but contribute little (5.7%) to infected cell
death. Additionally, when we did not constrain immune cells to
have a negative impact on viral load, the model fit was consistently
optimized by a solution in which NK cells have a positive effect on
viral load. This raises the question whether an alternative,
detrimental role for NK cells in HIV should be considered.
Consistent with this, several studies have found a positive
correlation between inhibitory KIR3DL1-NK cell receptors and
delayed disease progression [22,37]. Additionally, we have found
that inhibitory KIR receptors can enhance detrimental as well as
protective CD8+ T cell responses (NK Seich al Basatena & B
Asquith unpublished observations) possibly supporting a detri-
mental role for NK cells in some circumstances. One possibility is
that NK cells recruit CD4+ T cell to the site of infection, thus
supporting the establishment and spread of the infection.
Alternatively, NK cells could support HIV-infection by IFNc
production leading to immune activation which has been
implicated as a strong predictor of disease progression [76,77].
In our data set both the total NK population as well as the Ki67+
NK population showed a significant correlation with the number
of Ki67+ CD4 T cells (Spearman correlation coefficient R= 0.53
and 0.49, p = 6.5761028 and 5.361025 respectively). Our
unexpected finding that NK cells may increase viral load illustrates
the value of combining an impartial ‘‘hypothesis-free’’ empirical
approach with the more traditional approach of functional,
mechanistic models.
In summary, we show that CD4+ target cells and CD8+ T cells
are significant determinants and Granger-causal predictors of SIV
viraemia. The main causes of infected cell death are immune
(CD8, NK, B)-independent death (47%) and CD8+ T cell killing
(42%). We find that NK cells and B cells play a very limited role in
the control of viraemia being neither Granger causal predictors of
viral load nor significant determinants of viral load in a
mechanistic model and contributing little (both approximately
6%) to infected cell death. Of note we find evidence that the net
impact of NK cells may be detrimental for the host and lead to an
increase in viraemia.
Methods
Data
Animals were infected with SIVmac251 i.v. or SIVmac239 i.r. and
blood taken once a week for the first four weeks after infection and
subsequently every four or eight weeks up to 24 weeks after
infection. Viral RNA levels in plasma were quantitated using real-
time reverse transcriptase PCR. CD4+ T lymphocytes were
defined as CD3+CD82, CD8+ T lymphocytes as CD3+CD8+,
NK cells as CD32CD8+ and B cells as CD20+ lymphocytes. The
density of these populations in peripheral blood was determined by
multi-parameter flow cytometry. The fraction of proliferating
CD4+ T cells, CD8+ T cells, B cells and NK cells was assessed by
staining for the nuclear antigen Ki67, which is expressed by
cycling cells. SIV-specific CTL activity against Env and Gag was
determined after in vitro stimulation by 51Cr release assay. Seven of
the SIVmac239-infected macaques received a recombinant herpes
simplex virus (HSV) vaccine expressing the Envelope and Nef
proteins of SIVmac239 prior to infection. The data for some of the
macaques has previously been reported [69,78–80]. A one-way
analysis of variance (ANOVA) between treatment groups showed
no significant differences in viral load and number or fraction of
CD4+ T, CD8+ T, B or NK cells between the groups. Hence,
animals were clustered into one group.
Figure 2. Difference between model predictions and observed
data (sum of squared residuals). The x axis is the deviation of the
predictions of a CD8+ T cell model from the data; the y axis is the
deviation for the two alternative models, NK cell control model, and B
cell control model. All models have an equal number of parameters The
line is the line of equal SSR. It can be seen that the match between the
prediction and the observed data is best (lowest SSR) for the CD8+ T cell
model (p = 0.17 when compared to B cells, p = 0.02 when compared to
NK cells).
doi:10.1371/journal.pcbi.1001103.g002
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Figure 3. Experimental data and mechanistic model fits. Experimental viral load and viral load predicted by the target cell limitation model
and CD8 control model. B cell data was missing for 6 of the datasets and so the model with liberated parameter constraints could not be fitted for
these animals. The oscillations in the predicted viral load are due to variation in the experimental data underlying the empirical functions describing
the dynamics of target and immune cell populations. Smoothing of the input data reduces the fluctuations. Note: all datasets were fitted
simultaneously, not individually.
doi:10.1371/journal.pcbi.1001103.g003
Role of the Immune System in Primary SIV-Infection
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Ethics statement
Animals were maintained in accordance with the guidelines of
the Committee on Animals of the Harvard Medical School and
the Guide for the Care and Use of Laboratory Animals [78].
Granger causality (empirical model)
Granger causality examines whether the prediction of variable
Y based on past (lagged) information of this variable could be
improved by incorporating past information of another variable X.
If the ability to predict Y is significantly improved by including
past measurements of X, then X is said to have a weak-causal or
‘‘Granger-causal’’ influence on Y [81].
In this study bivariate Granger causality was implemented in the
form of prediction of the current value of viral load V(t), based on
lagged values of viral load V(t-t) and lagged values of X(t-t), where
the explanatory variable X represents either target cells (T) or one of
the immune populations, CD8+ T cells, CD20+ B cells or NK cells
(E). For this analysis we only used 11 data sets that have at least of 6
data points. We tested for Granger-causality in those macaque data
set using unequal time lags with lag-length based on available data,
increasing with time since infection from 2 to 4 to 8 wks.
logVt~azb log V t{ttð Þ½ zcX t{ttð ÞzRt ð1Þ
where tt is the lag at time t and R are the residuals or prediction
errors. Implementation of a more complex model, explicitly
incorporating the length of the time lags, did not change the results
of the analysis (data not shown). To test if combination of variables
can improve the prediction, the regression was extended to include
past viral load and both past target and past effector populations.
logVt~azb log V t{ttð Þ½ zcT t{ttð ÞzdE t{ttð ÞzRt ð2Þ
If there is no improvement of model accuracy this suggests the
corresponding variable has no direct effect on log[V(t-t)] [81].
Additionally, we reversed this analysis to address the question of
Granger-causal influence in the opposite direction, i.e. if past viral
load predicts future target or effector cell numbers.
Mechanistic models
To optimise the use of available experimental data, minimise
the number of parameters to be estimated and constrain the fits we
followed the novel approach of Regoes et al. [66]. This approach is
based on a dynamical model in which free virions (V) and infected
target cells (T*) are described by deterministic ordinary differential
equations.
dT
dt
bTV{dT{kTE ð3Þ
dV
dt
~pT{cV ð4Þ
In this model uninfected cells (T) are infected by free virus at rate b
to produce infected cells (T*) which die at rate d and are cleared by
immune effectors (E) at rate k. Free virus is produced by infected
target cells at a rate p and cleared at rate c. We assumed a quasi-
steady state between infected cells and free virus allowing us to
eliminate Eqn 4. The number of target cells and effector cells, T(t)
and E(t) were entered as empirical functions rather than predicted,
putting an extra constraint on fitting the measured viral load
dynamics, so the model reduces to
Table 2. Inference mechanistic models.
A. DDIC
CD8+ T cell immune control 42.5
NK cell immune control 0.7
B cell immune control 23.3
B
Ki67+ target cell limitation 23.2
Ki67+ CD8+ T cell control 227.6
Env- and Gag- specific T cell control 211.3
Ki67+ NK cell control 27.9
Ki67+ B cell control 214.3
C
CD8 and NK cell immune control 29.3
CD8 and B cell immune control 2.5
B and NK cell immune control 221.4
CD8, NK and B cell immune control 216.8
DDIC calculated as A) DIC target cell limitation model minus DIC immune
control model, B) DIC immune control model minus DIC Ki67+ immune control
model or DIC Env and Gag-specific immune control model and C) DIC CD8
control model minus DIC immune control models combining two or three
immune populations. As a rule of thumb we say we cannot distinguish between
two models when we find DDIC ,2, if DDIC is between 3 and 7 there is some
support for the 1st model but the 2nd model is clearly better, if DDIC is greater
than 10 essentially no support is found for the 1st model [90]. The model that
predicts the experimental data best is the CD8+ T cell immune control model (in
bold above).
doi:10.1371/journal.pcbi.1001103.t002
Table 3. Contribution to total cell death of intrinsic death
rate and the different immune populations.
Average (SD)
Intrinsic death rate 46.8% (16.9)
CD8+ T cell killing 41.8% (12.7)
B cell killing 5.7% (3.5)
NK cell killing 5.7% (4.2)
Contribution averaged over different time points and all animals is given,
standard deviation in brackets.
doi:10.1371/journal.pcbi.1001103.t003
Table 4. Contribution to R2.
Partitioned R2
VL 55.3
CD4+ T cells 17.6
CD8+ T cells 7.5
B cells 4.4
NK cells 15.3
The partitioned R2 indicates how much of the total variation in future viral load
is attributable to the various factors.
doi:10.1371/journal.pcbi.1001103.t004
Role of the Immune System in Primary SIV-Infection
PLoS Computational Biology | www.ploscompbiol.org 7 March 2011 | Volume 7 | Issue 3 | e1001103
dV
dt
~V rT tð Þ{d{kE tð Þð Þ ð5Þ
Where E(t) and T(t) are the empirical functions obtained by linear
interpolation between data points. Parameter d is the immune
(CD8, NK, B)-independent death rate of infected cells; k is the rate
of killing per effector cell per day and r (r = pb/c) is the replication
rate of the virus per target cell per day. Equation 5 can be solved
to give:
lnV tð Þ~ lnV0zr
ðt
t0
T tð Þdt{d t{t0ð Þ{k
ðt
t0
E tð Þdt ð6Þ
We refer to the version of the model (Eqn 6) in which the final
term is omitted as the target cell limitation model; the full model is
referred to as the immune control model. Immune effector
populations were either CD8+ T lymphocytes, NK cells or B cells.
We fitted the models to virus load measurements using both a
Bayesian and a more conventional least squares regression
approach. Additionally, to systematically test all possible combi-
nations of immune effector populations the last term of equation 6
was repeated, data of the different effector populations were
included and a separate k for each of the effector populations was
estimated. We only had data on B cells for 11 of the 17 macaques,
so models including the B cell populations were not fitted to all
data sets.
Although CD8+ T cells are thought to control infection
primarily via cytolysis there is also evidence for a non-lytic mode
of action. We therefore also considered a non-lytic model for
CD8+ T cells. In this model we assumed CD8+ T cell decrease the
rate of infection of target cells.
dT
dt
~
1
1zkE
bTV{dT ð7Þ
Replacing Eqn (3) with (7) gives:
dV
dt
~
r
1zkE
T{d
 
V ð8Þ
No analytical solution exists and, due to software limitations, we
fitted this model using the conventional least squares regression
approach only.
Although a cytotoxic role for B cells has been described,
especially in acute infection, [82,83] the main mode of B cell
protection is thought to be via neutralizing antibodies. We
modelled this by assuming that the number of B cells was
proportional to the amount of neutralizing antibodies and built a
model in which antibodies reduce the infection rate of uninfected
target cells.
dT
dt
~ b{nBð ÞVT{dT ð9Þ
Replacing (3) with (9) and solving gives:
lnV tð Þ~ lnV0zr
ðt
t0
T tð Þdt{d t{t0ð Þ{g
ðt
t0
T tð ÞB tð Þdt ð10Þ
Where r = pb/c and g=pn/c.
During primary SIV infection, total CD20+ lymphocyte
population correlates with both disease progression and virus-
binding antibodies [84] while total NK cell population significantly
correlates with proliferation (0.612, p,0.01) which, in turn,
parallels cytotoxicity [85,86]. The available data enabled us to
investigate the role of different immune cell populations and test
which explains the viral load data best. For CD4+ T cell, B cell and
NK cell populations we use both total populations and the
proliferating Ki67+ fraction. CD8 T cells were variously defined as
the total CD8+ T cell population, the Ki67+ fraction or the SIV-
specific fraction represented by Env and Gag specific lytic units.
Bayesian approach and MCMC
For the two models described above, parameters were estimated
by fitting all data from all animals simultaneously but allowing
parameters to vary from one macaque to another through random
effects that were assumed to be normally distributed. A Bayesian
approach was used to estimate the parameters. The Bayesian
approach to population modelling is particularly useful as it allows
the inclusion of prior knowledge in the form of informative prior
distributions of parameter values. It integrates the prior informa-
tion with the likelihood of the observed data to obtain a posterior
distribution [87]. The joint posterior distribution of model
parameters and data was explored by Markov chain Monte Carlo
(MCMC) sampling [88]. Following Gelman and Rubin [89], 3
chains were run from different starting values until convergence,
based on diagnosis of Brooks-Gelman-Rubin plots, was reached.
Subsequently, the chains were run for a further 50,000 iterations
and posterior distributions of each parameter, model fit and
Deviance Information Criterion (DIC) were determined.
In the mechanistic models all priors were assumed to be normal
and truncated to constrain the parameters to positive values. The
mean and precision of the priors was based on estimates from the
literature (Table 5). In the Granger analysis the parameters do not
have a biological interpretation and so we choose uninformative
Table 5. Prior distributions of the parameters in the
mechanistic models.
parameter mean precision reference
d 7.0 0.48 Markowitz et al 2003 [92]
r 0.21 0.001 Regoes et al 2004, Perelson
et al 1996 [66,93]
kCD8 0.0025 350 Based on Markowitz et al
2003 [92]
kNK 0.0058 150 Idem
kB 0.0035 250 Idem
All parameters were assumed to be positive and prior distributions truncated at
0. r = production rate virus per target cell per week, d= death rate of infected
cells per week, k = killing rate per immune cell per week. In the immune control
model the prior distribution of d is changed to mean 3.5 and precision 0.25, in
order to obtain a prior distribution of the total death rate (d+kE) that is
consistent with published data [92].
doi:10.1371/journal.pcbi.1001103.t005
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priors with mean 0 for all parameters. Parameters can be the same
for the whole population or allowed to vary between different
animals, by using random effects. In order to restrict the number
of effective parameters to the minimum needed we tested both
options for all parameters but concluded that individual parameter
values for each animal gave substantial better fits for all models,
except the target cell model. All fits were performed in WinBUGS
1.4.3 (Imperial College and Medical Research Council, UK).
Model inference/DIC
Significance of model fit was assessed by the Deviance
Information Criterion (DIC), a Bayesian generalisation of the
Akaike Information Criterion. Like the Akaike Information
Criterion, the DIC is based on the goodness of fit penalized by
the effective number of parameters or model complexity [90].
Model inference was based on the comparison between the DIC
of two models (DDIC = DIC1-DIC2). As a rule of thumb for
model inference Spiegelhalter et al [90] suggested that if models
differ by only one or two DIC units then one cannot distinguish
between the two models, if models differ by three to seven DIC
units there is some support for the 1st model but the 2nd model is
clearly better, or vice versa in the case of a negative DDIC. If the
difference in DIC is greater than 10 essentially no support is found
for the model with the higher DIC.
Least squares regression approach
As an alternative, and more traditional, approach the model
was also fit to the longitudinal data using non-linear least-squares
regression defined in a global optimization algorithm (GlobalSolve
from Maple ToolBox, MapleSoft, Canada). As opposed to the
Bayesian approach where parameter estimates are described as
random variables with a given distribution, this method provides
point estimates for all parameters and the goodness of fit is
described by the Sum of Squared Residuals. Comparison between
models was based on this goodness of fit. For nested models model
inference was based on an F-test on the individual data-sets
followed by Fishers combined probability test. For non-nested
models with an equal number of parameters we used a Wilcoxon
sign test on the Sum of Squared Residuals.
For most models included in this study the conclusions reached
by the two different approaches, Bayesian or least squares
regression, agreed and so we do not discuss them both. We limit
our discussion to the Bayesian approach and only include the least
squares approach to the cases where the conclusions differ.
Contribution to total death of infected cells
To determine the contribution of intrinsic cell death and immune
cell killing to the total death rate of productively infected CD4+ T
cells we divided the cell death attributable to intrinsic cell death (d in
equation 5) or attributable to one of the immune populations
(kxEx(t)) by the total death rate at that time point. Intrinsic death rate
and killing rates for each data set were determined in the model
including all three death rates. Average contribution over time and
standard deviation were determined. We also applied a more
intuitive definition, by determining the increase in viral load in
1 hour when omitting one of the death terms relative to the increase
in viral load found with the full model over the same time period.
Conclusions of both methods were comparable.
Partitioning of R2
To partition R2 according to the predictive power of each
variable we used average stepwise regression [91]. In this method
each variable’s contribution to R2 can be estimated by entering each
variable in the regression to viral load one by one and calculating
the increment in R2 after each addition. Because the contribution of
each variable is highly dependent on the order in which the variable
is included in the equation, in average stepwise regression all
possible orderings were considered and the average increment in R2
over all orderings was calculated. We looked at the contribution of
past values of viral load, CD4+ T cell, CD8+ T cells, NK cells and B
cells to explaining viral load variation in the total data set.
Supporting Information
Table S1 Sum of Squared residuals of lytic and non-lytic CD8+
T cell model. Sum of Squared residuals of lytic and The non-lytic
model (which has the same number of free parameters as the lytic
model) gives a significantly improved fit to the data. This supports
our conclusion that CD8+ T cells are important determinants of
viral dynamics and motivates further studies into non-lytic
mechanisms of CD8+ T cell control. Due to software limitations
we were only able to fit the non-lytic model using the conventional
least squares regression approach, for this reason the non-lytic
model does not appear in Table 3 (however, its inclusion could
only strengthen our conclusions as CD8+ T cells are already the
best predictors of viral load dynamics using a lytic model).
Found at: doi:10.1371/journal.pcbi.1001103.s001 (0.04 MB
DOC)
Table S2 Fitted parameter values mechanistic model. Parameter
values resulting from the fit of the mechanistic model including all
three immune effectors without constraints on parameter ranges of
the killing rates.
Found at: doi:10.1371/journal.pcbi.1001103.s002 (0.04 MB
DOC)
Table S3 Impact on viral load. Increase in viral load in 1 hour
when omitting the indicated death term compared to the increase
in viral load found with the full model over the same time period.
To calculate the viral load parameter values resulting from the
model fits are used. Increase in viral load is determined for each
macaque at different time points at 1 week intervals.
Found at: doi:10.1371/journal.pcbi.1001103.s003 (0.05 MB
DOC)
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